Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Psychemedics Corp.

www.psychemedics.com

Latest From Serum Institute of India Ltd.

Hilleman’s Pioneering Shigella Vaccine Set For First Trials

India’s Hilleman Laboratories, in partnership with a government agency, expects to start human trials this year with a pioneering multivalent vaccine to prevent shigellosis, a highly contagious bacterial diarrheal disease that is a major killer of children in low-income countries but has proven a difficult vaccine target.

Vaccines Infectious Diseases

Sun Dips Toe Into Vaccines With Dengvaxia Challenge

India's top-ranked drug firm Sun Pharma is vying for a play in the dengue vaccines space via a collaboration with the non-profit research organization, International Centre for Genetic Engineering and Biotechnology. The partners expect their vaccine candidate to potentially best live-attenuated dengue vaccine candidates, including Sanofi's Dengvaxia.

Research & Development Strategy

Cuba: A Pharmaceutical Regulatory Snapshot

Despite many restrictions, the nation is a potential market for imported drugs.

Review Pathway Research & Development

Cipla Sees Changed Profile; Wraps Up Europe Revamp

Cipla's management sees the firm's profile changing as it scales up its US business with new launches and a step-up in product filing intensity. The Indian company is also "largely done" with a restructuring in Europe that saw a significant cutback in personnel but is expected to make the European business profit-accretive.

Commercial Strategy
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Laboratory Testing Services
  • Services
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Psychemedics Corp.
  • Senior Management
  • Raymond C Kubacki, Chmn., Pres. & CEO
    Neil Lerner, VP, Fin.
    Jim Dyke, Corp. VP, Sales & Mktg.
  • Contact Info
  • Psychemedics Corp.
    Phone: (978) 206-8220
    125 Nagog Pk.
    Ste. 200
    Acton, MA 01720
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register